“ Candesartan significantly suppressed decrease in pancreatic weight and increases in pancreatic myeloperoxidase activity, hydroxyproline content, ratio of fibrous tissue, histologic scores, and ratio of α-smooth muscle actin-positive cells (activated pancreatic stellate cells) at 20 weeks.”